ArticlePharmaceutics2021
Endophytic Bacteria
Article in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 31 citations in OpenAlex.
- Endophytic bacteria associated with turmeric, ginger and white radish exhibit dual roles as producers of antibacterial metabolites and carriers of multidrug resistance.Scientific reports · 2026Article
- Antitumor and cytotoxic activities of endophytic Enterobacter hormaechei derived secondary metabolites: In-vitro and In-silico study.PloS one · 2025Article
- Article
- Article
- New Pyrroline Isolated from Antarctic Krill-Derived ActinomycetesMarine drugs · 2023Article
- Photocatalytic and Antimicrobial Activities of Biosynthesized Silver Nanoparticles UsingLife (Basel, Switzerland) · 2022Article
- Bioactivity-Guided Screening of Antimicrobial Secondary Metabolites from Antarctic Cultivable FungusMarine drugs · 2022Article
- Recent Advances in Green Synthesis of Ag NPs for Extenuating Antimicrobial Resistance.Nanomaterials (Basel, Switzerland) · 2022Review
- Silver and Gold Nanoparticles for Antimicrobial Purposes against Multi-Drug Resistance Bacteria.Materials (Basel, Switzerland) · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance (AMR), one of the greatest issues for humankind, draws special attention to the scientists formulating new drugs to prevent it. Great emphasis on the biological synthesis of silver nanoparticles (AgNPs) for utilization in single or combinatorial therapy will open up new avenues to the discovery of new antimicrobial drugs. The purpose of this study was to synthesize AgNPs following a green approach by using an endophytic bacterial strain,
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.